KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Return on Assets (2016 - 2025)

Historic Return on Assets for Regeneron Pharmaceuticals (REGN) over the last 16 years, with Q4 2025 value amounting to 0.11%.

  • Regeneron Pharmaceuticals' Return on Assets fell 100.0% to 0.11% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.11%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.12% for FY2025, which is 100.0% down from last year.
  • Regeneron Pharmaceuticals' Return on Assets amounted to 0.11% in Q4 2025, which was down 100.0% from 0.12% recorded in Q3 2025.
  • In the past 5 years, Regeneron Pharmaceuticals' Return on Assets ranged from a high of 0.33% in Q4 2021 and a low of 0.11% during Q4 2025
  • Over the past 5 years, Regeneron Pharmaceuticals' median Return on Assets value was 0.13% (recorded in 2023), while the average stood at 0.18%.
  • Per our database at Business Quant, Regeneron Pharmaceuticals' Return on Assets surged by 1200bps in 2021 and then plummeted by -1800bps in 2022.
  • Regeneron Pharmaceuticals' Return on Assets (Quarter) stood at 0.33% in 2021, then crashed by -54bps to 0.15% in 2022, then dropped by -21bps to 0.12% in 2023, then fell by -3bps to 0.12% in 2024, then fell by -5bps to 0.11% in 2025.
  • Its last three reported values are 0.11% in Q4 2025, 0.12% for Q3 2025, and 0.12% during Q2 2025.